Felim, A; Herrera, G; Neudõrffer, A; Blanco, M; O’Connor, J; Largeron, M. Synthesis and in vitro cytotoxicity profile of the R-enantiomer of 3,4-dihydroxymethamphetamine (R-(-)-HHMA): Comparison with related catecholamines. Chem. Res. Toxicol., 20 Jun 2011, 23 (1), 211–219. 349 kB. https://doi.org/10.1021/tx9003374
Clark, CC. The identification of methoxy-N-methylamphetamines. J. Forensic Sci., 1 Oct 1984, 29 (4), 1056–1071. 423 kB. https://doi.org/10.1520/JFS11772J #VIII GC,NMR,IR,UV
EMCDDA. New drugs in Europe, 2011, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Apr 2012. 401 kB.
Milhazes, N; Cunha-Oliveira, T; Martins, P; Garrido, J; Oliveira, C; Rego, AC; Borges, F. Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine (“Ecstasy”) and its metabolites on undifferentiated PC12 cells: A putative structure-toxicity relationship. Chem. Res. Toxicol., 1 Oct 2006, 19 (10), 1294–2304. 204 kB. https://doi.org/10.1021/tx060123i #17 MS,NMR,other
Clancy, L; Philp, M; Shimmon, R; Fu, S. Development and validation of a color spot test method for the presumptive detection of 25-NBOMe compounds. Drug Test. Anal., 19 Aug 2020, 13 (5), 929-943. 11.3 MB. https://doi.org/10.1002/dta.2905 #3,4-dimethoxymethamphetamine